UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 41 filers reported holding UROVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,707,000 | – | 167,787 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 157,480 | $1,583,000 | 1.24% |
| Sio Capital Management, LLC | 215,042 | $2,161,000 | 0.58% |
| Prosight Management, LP | 99,870 | $1,004,000 | 0.44% |
| Perceptive Advisors | 865,359 | $8,697,000 | 0.24% |
| Eventide Asset Management | 669,000 | $6,723,000 | 0.23% |
| Park West Asset Management LLC | 432,500 | $4,347,000 | 0.19% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,385,000 | $13,919,000 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 51,100 | $514,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 539,889 | $5,426,000 | 0.01% |
| Weiss Multi-Strategy Advisers LLC | 15,000 | $151,000 | 0.00% |